Kotyla, P.J.; Kruszec-Zytniewska, A.; Owczarek, A.J.; Olszanecka-Glinianowicz, M.; Chudek, J.
Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker. J. Clin. Med. 2018, 7, 558.
https://doi.org/10.3390/jcm7120558
AMA Style
Kotyla PJ, Kruszec-Zytniewska A, Owczarek AJ, Olszanecka-Glinianowicz M, Chudek J.
Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker. Journal of Clinical Medicine. 2018; 7(12):558.
https://doi.org/10.3390/jcm7120558
Chicago/Turabian Style
Kotyla, Przemyslaw J., Aneta Kruszec-Zytniewska, Aleksander J. Owczarek, Magdalena Olszanecka-Glinianowicz, and Jerzy Chudek.
2018. "Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker" Journal of Clinical Medicine 7, no. 12: 558.
https://doi.org/10.3390/jcm7120558
APA Style
Kotyla, P. J., Kruszec-Zytniewska, A., Owczarek, A. J., Olszanecka-Glinianowicz, M., & Chudek, J.
(2018). Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker. Journal of Clinical Medicine, 7(12), 558.
https://doi.org/10.3390/jcm7120558